MYCN and neoplasm: Histological assessment of whole tissue sections of samples harvested at 48 hrs revealed significantly higher necrosis and CC3 staining, and significantly lower Ki67, CD34 and VEGFR2 staining, in tumours from the cabozantinib-treated Th-MYCN mice (Fig. 2).